Literature DB >> 24789428

Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.

Ming Yang1, Xiaoxia Wang, Qi Zhao, Tianbo Liu, Guodong Yao, Wenhao Chen, Zhiwei Li, Xiaoyi Huang, Yanqiao Zhang.   

Abstract

Nuclear ubiquitous casein and cyclin-dependent kinases substrate (NUCKS) has been recently documented in various malignancies. However, data regarding the expression and prognostic value of NUCKS in gastric adenocarcinoma are limited. Specimens from 159 gastric adenocarcinoma patients who underwent primary gastrectomy were collected. Immunohistochemical method was used to evaluate NUCKS and Ki-67 expression. The correlations between NUCKS and clinical significance were analyzed. Elevated NUCKS expression was significantly associated with TNM stage (P = 0.034), depth of invasion (P = 0.001), and expression of Ki-67 (P = 0.035). Kaplan-Meier analysis indicated that NUCKS overexpression alone (P = 0.045 for overall survival) or in combination with Ki-67 (P = 0.007 for disease-free survival, P = 0.002 for overall survival) was correlated with adverse prognosis of the patients. Multivariate analysis revealed that combined NUCKS and Ki-67 overexpression was an independent prognostic factor for both disease-free survival (hazard ratio = 1.623, P = 0.02) and overall survival (hazard ratio = 1.667, P = 0.016) in gastric adenocarcinoma patients. The combination of NUCKS and Ki-67 overexpression in gastric adenocarcinoma further distinguished a subgroup of patients with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789428     DOI: 10.1007/s13277-014-1880-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Identification and confirmation of a module of coexpressed genes.

Authors:  H Garrett R Thompson; Joseph W Harris; Barbara J Wold; Stephen R Quake; James P Brody
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics.

Authors:  Jacek R Wiśniewski; Alexandre Zougman; Sonja Krüger; Piotr Ziółkowski; Marek Pudełko; Marek Bebenek; Matthias Mann
Journal:  Proteins       Date:  2008-11-15

4.  A novel nucleic acid-binding protein that interacts with human rad51 recombinase.

Authors:  O V Kovalenko; E I Golub; P Bray-Ward; D C Ward; C M Radding
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.

Authors:  M Victorzon; P J Roberts; C Haglund; K von Boguslawsky; S Nordling
Journal:  Oncology       Date:  1996 May-Jun       Impact factor: 2.935

6.  Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis.

Authors:  Tzeela Cohen; Diana Prus; Jinru Shia; Bassam Abu-Wasel; Meir G Pinto; Herbert R Freund; Alexander Stojadinovic; Anna Grakov; Tamar Peretz; Aviram Nissan
Journal:  J Surg Oncol       Date:  2008-04-01       Impact factor: 3.454

7.  Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains.

Authors:  Linda M Sargent; Mang X Ensell; Anne-Carine Ostvold; Kimberly T Baldwin; Michael L Kashon; David T Lowry; Jamie R Senft; Amy M Jefferson; Robert C Johnson; Zhi Li; Frederick L Tyson; Steven H Reynolds
Journal:  Toxicol Appl Pharmacol       Date:  2008-02-08       Impact factor: 4.219

8.  High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.

Authors:  Tara L Naylor; Joel Greshock; Yan Wang; Theresa Colligon; Q C Yu; Virginia Clemmer; Tal Z Zaks; Barbara L Weber
Journal:  Breast Cancer Res       Date:  2005-11-24       Impact factor: 6.466

9.  Immunohistochemical and proteomic evaluation of nuclear ubiquitous casein and cyclin-dependent kinases substrate in invasive ductal carcinoma of the breast.

Authors:  Piotr Ziółkowski; Elzbieta Gamian; Beata Osiecka; Alexandre Zougman; Jacek R Wiśniewski
Journal:  J Biomed Biotechnol       Date:  2009-12-24

10.  Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.

Authors:  E C Inwald; M Klinkhammer-Schalke; F Hofstädter; F Zeman; M Koller; M Gerstenhauer; O Ortmann
Journal:  Breast Cancer Res Treat       Date:  2013-05-16       Impact factor: 4.872

View more
  8 in total

1.  Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.

Authors:  Tianbo Liu; Shu Tan; Ye Xu; Fanling Meng; Chang Yang; Ge Lou
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

Review 2.  Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.

Authors:  Guanying Luo; Yunzhao Hu; Zhiqiao Zhang; Peng Wang; Zhaowen Luo; Jinxin Lin; Canchang Cheng; You Yang
Journal:  Oncotarget       Date:  2017-07-25

3.  Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis.

Authors:  Gang Liu; Disheng Xiong; Junjie Zeng; Borong Chen; Zhengjie Huang
Journal:  Onco Targets Ther       Date:  2017-09-01       Impact factor: 4.147

4.  Ki-67/MKI67 as a Predictive Biomarker for Clinical Outcome in Gastric Cancer Patients: an Updated Meta-analysis and Systematic Review involving 53 Studies and 7078 Patients.

Authors:  Dan-Dan Xiong; Chu-Mei Zeng; Ling Jiang; Dian-Zhong Luo; Gang Chen
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

5.  NUCKS1 is a novel RAD51AP1 paralog important for homologous recombination and genome stability.

Authors:  Ann C Parplys; Weixing Zhao; Neelam Sharma; Torsten Groesser; Fengshan Liang; David G Maranon; Stanley G Leung; Kirsten Grundt; Eloïse Dray; Rupa Idate; Anne Carine Østvold; David Schild; Patrick Sung; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2015-08-31       Impact factor: 16.971

6.  Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice.

Authors:  Yangbo Yue; Stanley G Leung; Yueyong Liu; Yurong Huang; Kirsten Grundt; Anne-Carine Østvold; Kuang-Yu Jen; David Schild; Jian-Hua Mao; Claudia Wiese
Journal:  Oncotarget       Date:  2016-09-20

Review 7.  Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms.

Authors:  Pengru Huang; Yujie Cai; Bin Zhao; Lili Cui
Journal:  Biomed Res Int       Date:  2018-01-29       Impact factor: 3.411

8.  NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer.

Authors:  Erhu Zhao; Liying Feng; Longchang Bai; Hongjuan Cui
Journal:  J Exp Clin Cancer Res       Date:  2020-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.